Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children ...
In PV and ET, MDS risk remains lower than AML risk but increases progressively with advancing attained age. Transformation to acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in ...
For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...
Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 ...
A Winston-Salem father and daughter share their story of hope after a rare, perfect stem cell match helps him treat acute ...
Limited "Joel's Wildfire" Series Expected to Raise Over $40,000 RICE LAKE, Wis., March 17, 2026 /PRNewswire/ -- Henry Repeating Arms, one of the country's leading firearms manufacturers, is donating a ...
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global ...
AUSTIN — Ashley Park didn't want to go to the emergency room. She just wanted to rehearse for her "American Idol"-inspired ...
Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That ...
Fifth-grader Levi Buxman of Wooster has amassed more than 4,000 beads signifying various aspects of treatment for B-cell ...
Drs. Jessa Miller and Amrita Ray discuss the paradox of increasing incidence and decreasing mortality in AIFRS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results